Related Experiment Video
Updated: Jan 9, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
Analyzing Basal Insulin Dosing as Perturbations in Compositional Glycemic Profiles for Time in Range in Type 1
Summary
This study uses Compositional Data Analysis (CoDa) to model basal insulin adjustments in Type 1 Diabetes (T1D). The new approach helps predict glycemic control, improving treatment personalization and reducing trial-and-error in insulin titration.
Area of Science:
- Endocrinology
- Computational Biology
- Data Science
Background:
- Basal insulin dosing is critical for Type 1 Diabetes (T1D) management with multiple daily injections.
- Adjusting basal insulin remains a complex challenge for clinicians, impacting glycemic control.
Purpose of the Study:
- To introduce a novel decision support system using Compositional Data Analysis (CoDa) to model basal insulin perturbations.
- To assess the impact of basal insulin adjustments on glycemic control, including time in range (TIR) and glycemic distribution.
- To develop a predictive model for personalized T1D treatment strategies.
Main Methods:
- In silico simulations using a virtual cohort of 49 adults over 180 days.
- Application of Compositional Data Analysis (CoDa) to model basal insulin adjustments (±5%, ±10%, ±15%).
- Multivariate linear regression to predict glycemic outcomes and correlation analysis with a glycemic risk index.
Main Results:
- The CoDa framework successfully quantified the impact of basal insulin perturbations on TIR, with high R² values (up to 0.85).
- A strong negative correlation (r = -0.9141) was found between a CoDa-derived log-ratio coordinate and a glycemic risk index.
- A visualization panel was developed integrating arithmetic mean TIR, geometric mean TIR, and glycemic profile distributions.
Conclusions:
- CoDa analysis provides a robust framework for understanding basal insulin's effect on glycemic control in T1D.
- The developed decision support system aids physicians in optimizing basal insulin titration, reducing empirical adjustments.
- This approach facilitates personalized treatment strategies and improves overall T1D management.
More Related Videos
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
658
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
658
Insulin Formulations: Types and Delivery
622
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
622
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Dosage Regimen: Individualization
154
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
154
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K

